Could a tiny zap to the face soothe chronic eye pain?
NCT ID NCT07166848
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests whether a non-invasive electrostimulation device can relieve symptoms of chronic ocular graft-versus-host disease, a painful eye condition that can occur after a stem cell transplant. Fifteen participants will receive either real or sham stimulation on their cheeks and forehead for 30 minutes over 10 sessions. The goal is to see if the treatment reduces eye discomfort and helps regenerate corneal nerves.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- electrostimulation device
- What this could lead to
- If it works, this could offer a non-drug way to reduce eye pain and dryness in people with chronic ocular graft-versus-host disease.
- What could go wrong
- This is a very small pilot study with only 15 people, so results may not apply widely. The treatment is still experimental and may not provide lasting relief.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OCULAR GRAFT-VERSUS-HOST DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Massachusetts Eye and Ear - Longwood Campus
RECRUITINGBoston, Massachusetts, 02215, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.